| scholarly article | Q13442814 |
| P50 | author | Charles W McMonnies | Q89539992 |
| P2860 | cites work | Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease | Q26746232 |
| Review: The Lacrimal Gland and Its Role in Dry Eye | Q26752722 | ||
| Incomplete blinking: exposure keratopathy, lid wiper epitheliopathy, dry eye, refractive surgery, and dry contact lenses | Q33270245 | ||
| The overlap of Sjögren's syndrome with other systemic autoimmune diseases | Q33372729 | ||
| The epidemiology of Sjögren's syndrome | Q34004258 | ||
| Effect of inflammation on lacrimal gland function. | Q34338027 | ||
| Tear film changes associated with normal aging | Q34389583 | ||
| Tearful relationships? Sex, hormones, the lacrimal gland, and aqueous-deficient dry eye. | Q34600425 | ||
| Evidence for the major contribution of evaporation to tear film thinning between blinks. | Q34662161 | ||
| Topical cyclosporine A in the treatment of dry eye: a systematic review and meta-analysis | Q35166231 | ||
| Impact of evaporation on aqueous tear loss | Q35662640 | ||
| Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease | Q35907009 | ||
| Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction: Proceedings of the OCEAN group meeting. | Q36263410 | ||
| Anatomy and histopathology of the human lacrimal gland | Q36603889 | ||
| Dry eye disease: an immune-mediated ocular surface disorder | Q36916372 | ||
| Treatment of primary Sjögren syndrome: a systematic review | Q37776086 | ||
| Clinical Review: Topical Ophthalmic Use of Cyclosporin A | Q37782084 | ||
| Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting | Q38151227 | ||
| Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease. | Q38171801 | ||
| Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis | Q38220995 | ||
| Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-analysis | Q38516740 | ||
| TFOS DEWS II Epidemiology Report | Q38652994 | ||
| TFOS DEWS II Definition and Classification Report. | Q38665717 | ||
| TFOS DEWS II Management and Therapy Report | Q39453364 | ||
| Regulation of tear secretion. | Q40670983 | ||
| The cotton thread test: a brief review and a clinical study of its reliability on Hong Kong-Chinese | Q40783111 | ||
| Better methods of clinically assessing mucus functions are required | Q42365781 | ||
| Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications | Q43482891 | ||
| A new approach for better comprehension of diseases of the ocular surface | Q44020701 | ||
| Correlation of lipid layer thickness measurements with fluorescein tear film break-up time and Schirmer's test | Q44310196 | ||
| The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study | Q44600963 | ||
| The Relationship between Habitual Patient-Reported Symptoms and Clinical Signs among Patients with Dry Eye of Varying Severity | Q44631963 | ||
| Interexaminer difference and the effect of training on the phenol red thread test results in Hong Kong-Chinese. | Q44701688 | ||
| Schirmer test. II. A clinical study of its repeatability | Q44971361 | ||
| Conjunctival Tear Layer Temperature, Evaporation, Hyperosmolarity, Inflammation, Hyperemia, Tissue Damage, and Symptoms: A Review of an Amplifying Cascade | Q47807844 | ||
| Direct visualization of aqueous tear secretion from lacrimal gland. | Q50194254 | ||
| In vivo tear film thickness measurement and tear film dynamics visualization using spectral domain optical coherence tomography | Q60699392 | ||
| Dry eye disease immune responses and topical therapy | Q64099037 | ||
| Is the lacrimal gland dispensable? Keratoconjunctivitis sicca after lacrimal gland removal | Q66916036 | ||
| Tear film stability and tear surface tension | Q69637672 | ||
| Tear evaporation dynamics in normal subjects and subjects with obstructive meibomian gland dysfunction | Q78852996 | ||
| Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007) | Q80347912 | ||
| Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study | Q83540737 | ||
| Interferometry in the evaluation of precorneal tear film thickness in dry eye | Q85245821 | ||
| Topical cyclosporine: are all indications justified? | Q87154377 | ||
| Incidence and Risk Factors of Dry Eye in a Spanish Adult Population: 11-Year Follow-Up From the Salnés Eye Study | Q90688114 | ||
| Ocular Distribution of Cyclosporine Following Topical Administration of OTX-101 in New Zealand White Rabbits | Q92246579 | ||
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 6 | |
| P577 | publication date | 2020-02-01 | |
| P1433 | published in | Eye and vision (London, England) | Q27726793 |
| P1476 | title | Aqueous deficiency is a contributor to evaporation-related dry eye disease | |
| P478 | volume | 7 |
Search more.